February 19, 2022 Comments Off on New patent for Biocryst drug ORLADEYO Posted in: Patent Added Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are five patents protecting this drug. This drug has forty-eight…
The post New patent for Biocryst drug ORLADEYO appeared first on Dru…
February 18, 2022 Comments Off on New patent for Aveo Pharms drug FOTIVDA Posted in: Patent Added Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Aveo Pharms drug FOTIVDA appeared first on DrugPatentWatc…